BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1135607)

  • 41. Effects of general anaesthesia on portal venous pressure in the rat.
    Belghiti J; Blanchet L; Lebrec D
    Eur Surg Res; 1981; 13(4):285-9. PubMed ID: 7285995
    [No Abstract]   [Full Text] [Related]  

  • 42. Nitroglycerin in the treatment of portal hypertension.
    Sweeting J
    Gastroenterology; 1991 Aug; 101(2):552-3. PubMed ID: 1906030
    [No Abstract]   [Full Text] [Related]  

  • 43. Important details to be clarified about the effect of rectal ozone on the portal vein oxygenation.
    Bocci V; Zanardi I; Travagli V
    Br J Clin Pharmacol; 2011 Aug; 72(2):350-1; author reply 352. PubMed ID: 21446933
    [No Abstract]   [Full Text] [Related]  

  • 44. [Use of levamisole in liver cirrhosis].
    Patsiora MD; Glezer GA; Ershov IuA; Rachkov SM; Morozov VA
    Klin Khir (1962); 1981 Mar; (3):19-21. PubMed ID: 6971365
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hemodynamic study of non obstructive myocardiopathies of undetermined origin].
    Bourdarias JP; Ourbak P; Penther P; Scebat L; Lenegre J
    Acta Cardiol; 1966; 21(3):285-315. PubMed ID: 5296716
    [No Abstract]   [Full Text] [Related]  

  • 46. Isoproterenol in primary hypertension.
    Hultgren HN; Shettigar UR
    Am J Cardiol; 1980 Feb; 45(2):529-30. PubMed ID: 7355748
    [No Abstract]   [Full Text] [Related]  

  • 47. Selective intra-arterial vasopressin: clinical efficacy and complications.
    Sherman LM; Shenoy SS; Cerra FB
    Ann Surg; 1979 Mar; 189(3):298-302. PubMed ID: 311622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Arterial vasopressin infusions: science or seance?
    Nusbaum M; Conn HO
    Gastroenterology; 1975 Jul; 69(1):263-7. PubMed ID: 1097293
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmacokinetic-hemodynamic interactions in cirrhosis.
    Blei AT
    Semin Liver Dis; 1986 Nov; 6(4):299-308. PubMed ID: 3544223
    [No Abstract]   [Full Text] [Related]  

  • 50. The hemodynamic response of cirrhotic patients to the combined administration of vasopressin and isoproterenol.
    Sirinek KP; Thomford NR
    Rev Surg; 1975; 32(3):217-20. PubMed ID: 1135607
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of vasopressin on portal hypertension following hepatectomy.
    Sirinek KR; Thomford NR
    Surg Gynecol Obstet; 1974 Oct; 139(4):573-7. PubMed ID: 4419573
    [No Abstract]   [Full Text] [Related]  

  • 52. Portal and systemic effects of selective infusion of vasopressin into the superior mesenteric artery in cirrhotic patients.
    Millette B; Huet PM; Lavoie P; Viallet A
    Gastroenterology; 1975 Jul; 69(1):6-12. PubMed ID: 1150036
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Portohepatic pressures, hepatic function, and blood gases in the combination of nitroglycerin and vasopressin: search for additive effects in cirrhotic portal hypertension.
    Iwao T; Toyonaga A; Ikegami M; Sumino M; Oho K; Sakaki M; Nishizono M; Tanikawa K
    Am J Gastroenterol; 1992 Jun; 87(6):719-24. PubMed ID: 1590307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isoproterenol in offsetting adverse effects of vasopressin in cirrhotic patients.
    Sirinek KR; Thomford NR
    Am J Surg; 1975 Feb; 129(2):130-6. PubMed ID: 1078945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Use of calcium-channel blockers in cirrhotic patients with portal hypertension].
    Li D
    Zhonghua Yi Xue Za Zhi; 1990 Jul; 70(7):370-4, 26. PubMed ID: 2171726
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.